SG32393G - Sulphonic-acid esters - Google Patents

Sulphonic-acid esters

Info

Publication number
SG32393G
SG32393G SG32393A SG32393A SG32393G SG 32393 G SG32393 G SG 32393G SG 32393 A SG32393 A SG 32393A SG 32393 A SG32393 A SG 32393A SG 32393 G SG32393 G SG 32393G
Authority
SG
Singapore
Prior art keywords
substituted
compounds
acid esters
c7alkyl
unsubstituted
Prior art date
Application number
SG32393A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of SG32393G publication Critical patent/SG32393G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Detergent Compositions (AREA)
SG32393A 1985-06-13 1993-03-23 Sulphonic-acid esters SG32393G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH250185 1985-06-13

Publications (1)

Publication Number Publication Date
SG32393G true SG32393G (en) 1993-05-21

Family

ID=4235223

Family Applications (1)

Application Number Title Priority Date Filing Date
SG32393A SG32393G (en) 1985-06-13 1993-03-23 Sulphonic-acid esters

Country Status (18)

Country Link
US (2) US4785089A (enEXAMPLES)
EP (1) EP0206993B1 (enEXAMPLES)
JP (2) JPS61289073A (enEXAMPLES)
KR (1) KR940007529B1 (enEXAMPLES)
AT (1) ATE53014T1 (enEXAMPLES)
CA (1) CA1338089C (enEXAMPLES)
CY (1) CY1710A (enEXAMPLES)
DD (2) DD266097A5 (enEXAMPLES)
DE (1) DE3671439D1 (enEXAMPLES)
DK (2) DK170277B1 (enEXAMPLES)
ES (2) ES8801197A1 (enEXAMPLES)
FI (1) FI86171C (enEXAMPLES)
HK (1) HK63293A (enEXAMPLES)
HU (1) HU203074B (enEXAMPLES)
IE (1) IE58477B1 (enEXAMPLES)
IL (1) IL79077A (enEXAMPLES)
PT (1) PT82744B (enEXAMPLES)
SG (1) SG32393G (enEXAMPLES)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
US5145864A (en) * 1987-09-15 1992-09-08 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5371014A (en) * 1988-02-12 1994-12-06 Daicel Chemical Industries, Ltd. Process for the production of optically active 2-hydroxy acid esters using microbes to reduce the 2-oxo precursor
ATE98697T1 (de) * 1988-06-06 1994-01-15 Ciba Geigy Ag Verfahren zur herstellung von hydroxysaeuren.
JP3915015B2 (ja) 1995-08-22 2007-05-16 味の素株式会社 光学活性２−ヒドロキシ−４−アリール酪酸またはそのエステルの製造方法
JP2002509906A (ja) * 1998-03-31 2002-04-02 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド Ｈｐｂエステルの製造方法
AU2000239828A1 (en) * 2000-04-18 2001-10-30 Scinopharm Singapore Pte Ltd Process for preparation of 3-((1'-(alkoxycarbonyl)-3'-phenylpropyl)amino)-2-oxo-(1)- benzazepine and its derivatives
CA2442573A1 (en) * 2001-03-27 2002-10-03 Rajesh Kumar Thaper Process for the preparation of benazepril
EP1291336A3 (en) * 2001-09-05 2003-10-08 Solvias AG Preparation of optically active alpha-hydroxyethers
ITMI20020934A1 (it) 2002-05-03 2003-11-03 Danimite Dipharma S P A Processo per la sintesi di benazepril cloridrato
AU2003247159A1 (en) * 2003-07-07 2005-01-21 Hetero Drugs Limited A novel process for the preparation of cilazapril
WO2007015263A2 (en) * 2005-05-12 2007-02-08 Lupin Limited Improved process for crystallization of benazepril hydrochloride
CN105061312B (zh) * 2015-07-17 2017-12-12 惠州信立泰药业有限公司 一种改进的盐酸贝那普利的制备方法及含有该盐酸贝那普利的药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535060A (en) * 1978-09-05 1980-03-11 Agency Of Ind Science & Technol Asymmetric hydrogenation of alpha-keto-acid ester
JPS5823861B2 (ja) * 1979-06-05 1983-05-18 工業技術院長 α−ケトエステルの不斉水素化方法
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
EP0072352B1 (de) * 1981-08-11 1986-03-05 Ciba-Geigy Ag Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
EP0081320A3 (en) * 1981-12-07 1984-07-18 Beecham Group Plc Preparation of acetic acid derivatives
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4470988A (en) * 1983-02-10 1984-09-11 Ciba-Geigy Corporation Benzazocinone and benzazoninone derivatives, and their pharmaceutical use
DE3315464A1 (de) * 1983-04-28 1984-10-31 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
DE3328986A1 (de) * 1983-08-11 1985-02-21 Degussa Ag, 6000 Frankfurt Verfahren zur praktisch stereospezifischen herstellung von optisch aktiven (alpha)-aminocarbonsaeureestern
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation

Also Published As

Publication number Publication date
DE3671439D1 (de) 1990-06-28
FI862462A7 (fi) 1986-12-14
EP0206993B1 (de) 1990-05-23
CY1710A (en) 1994-01-14
FI86171C (fi) 1992-07-27
DK170277B1 (da) 1995-07-24
JPH05310656A (ja) 1993-11-22
IL79077A (en) 1994-01-25
KR940007529B1 (ko) 1994-08-19
PT82744B (pt) 1988-12-15
IE58477B1 (en) 1993-09-22
HU203074B (en) 1991-05-28
DD283611A5 (de) 1990-10-17
JPH0567140B2 (enEXAMPLES) 1993-09-24
KR870000291A (ko) 1987-02-17
US5066801A (en) 1991-11-19
HK63293A (en) 1993-07-09
DK171950B1 (da) 1997-08-25
JPS61289073A (ja) 1986-12-19
FI86171B (fi) 1992-04-15
DD266097A5 (de) 1989-03-22
IE861571L (en) 1986-11-13
EP0206993A1 (de) 1986-12-30
US4785089A (en) 1988-11-15
DK276386D0 (da) 1986-06-12
IL79077A0 (en) 1986-09-30
ES555954A0 (es) 1987-12-16
FI862462A0 (fi) 1986-06-09
ATE53014T1 (de) 1990-06-15
ES557722A0 (es) 1988-03-16
ES8801197A1 (es) 1987-12-16
ES8802013A1 (es) 1988-03-16
DK276386A (da) 1986-12-14
DK39695A (da) 1995-04-07
CA1338089C (en) 1996-02-27
PT82744A (en) 1986-07-01
JPH0735358B2 (ja) 1995-04-19

Similar Documents

Publication Publication Date Title
CY1710A (en) Sulphonic-acid esters
ATE49195T1 (de) Herstellung von fibraten.
GB1513824A (en) 1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizine derivative
AU5898580A (en) Pyroglutamic acid derivatives
ES2005746A6 (es) Un procedimiento para la preparacion de un haluro de piridinio.
ATE47138T1 (de) Verfahren zur herstellung von 1,2-dithiolan-3pentans|ure (thioctsaeure).
SE8601646D0 (sv) Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
HUP0104944A2 (hu) Acetamidot és szubsztituált acetamidot tartalmazó tiokarbamidok, mint herpeszvírus inhibitorok és ezeket tartalmazó gyógyszerkészítmények
GB2014137A (en) Optically-active substituted acetic acid derivatives
NO831743L (no) Fremgangsmaate ved fremstilling av aminoalkadienderivater
ES517995A0 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
GB8521516D0 (en) Compounds
ES522418A0 (es) Un procedimiento para preparar -15-desoxiespergualina.
ES8103040A1 (es) Un procedimiento de preparacion de una 7-acilindolin-2-ona
ES2060375T3 (es) Un procedimiento para descomponer acidos peroxicarboxilicos.
DE3469527D1 (en) Nortropine derivative, process for its preparation and its use
ES8704447A1 (es) Un procedimiento para preparar el homero s de un 3-eter de 2-hidroxi -profil-amina.
ATE8883T1 (de) Verfahren zur herstellung von nbenzylsubstituierten imiden.
ES8307254A1 (es) Un procedimiento para la preparacion de un enantiomero de beta-lactama.
ES8301230A1 (es) Un procedimiento para la preparacion de 1-fenil-5-amidotetrazoles.
PT81422A (en) Process for the preparation of 3-amino-2,3-dihidro-1-benzoxepincompounds
ES2049652B1 (es) Procedimiento para la preparacion de un acido quinolin carboxilico.
JPS5553264A (en) 3-(n-substituted carbamoylthio)-2(s)-methylpropionic acid
FR2446818A1 (fr) Tetrahydro-2h-benzo(c)pyrroles utiles comme intermediaires
FI882956L (fi) 4-piperidyl-substituerade karboxylsyraderivat och foerfarande foer deras framstaellning.